News Image

Friday's pre-market session: top gainers and losers

By Mill Chart

Last update: Jan 27, 2023

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Pre-market gainers

TickerChangeComment
WISA10.0K%WISA TECHNOLOGIES INC (NASDAQ:WISA) rose 10.0K% to $11.11 during Friday's pre-market session. After yesterday's drop of -19.39%, it looks like it is bouncing back in today's pre-market session. A press release (WiSA Technologies Announces Reverse Stock Split) was released yesterday.
MRKR779.0%MARKER THERAPEUTICS INC's (NASDAQ:MRKR) shares rose 779.0% to $3.1. After yesterday's drop of -11.8%, it looks like it is bouncing back in today's pre-market session.
AUVI54.81%APPLIED UV INC's (NASDAQ:AUVI) stock price increased by 54.81% to $1.61. A press release (Applied UV, Inc. Retains Legal Counsel to Investigate Potential Illegal Naked Short Selling) was released earlier today.
BZFD38.76%BUZZFEED INC's (NASDAQ:BZFD) stock price is advancing with 38.76% to a price of $2.9. Also in the previous session NASDAQ:BZFD had a very good day: shares closed with a 120.0% gain.
RDHL38.51%REDHILL BIOPHARMA LTD-SP ADR's (NASDAQ:RDHL) shares rose 38.51% to $0.26 during Friday's pre-market session. Shareholders saw the stock price going 33.6% higher in the past month.
AKAN26.43%AKANDA CORP's (NASDAQ:AKAN) stock price is advancing with 26.43% to a price of $0.35. Yesterday's gain of 47.37% continues in today's pre-market with 26.43%.
FOXO17.65%FOXO TECHNOLOGIES INC's (NYSEARCA:FOXO) stock price is advancing with 17.65% to a price of $0.6. Yesterday's gain of 24.42% continues in today's pre-market with 17.65%.
TCBP17.19%TC BIOPHARM HOLDINGS PLC-ADR's (NASDAQ:TCBP) stock price is advancing with 17.19% to a price of $6.68. Yesterday's gain of 40.74% continues in today's pre-market with 17.19%.
GFAI15.96%GUARDFORCE AI CO LTD's (NASDAQ:GFAI) stock price is advancing with 15.96% to a price of $0.28. This is a continuation of yesterday's gain of 14.29%.
POL15.87%POLISHED.COM INC's (NYSEARCA:POL) stock price is advancing with 15.87% to a price of $0.62. Shareholders saw the stock price going 54.66% lower is the past 6 months.

Our premarket gainers screener will show you the full list.

Today's pre-market losers

TickerChangeComment
SI-A-33.19%SILVERGATE CAP CORP - SI 5 3/8 PERP's (NYSE:SI-A) stock price is declining with 33.19% to a price of $7.65. In the last 6 months the share price dropped with 41.28%.
CFRX-23.45%CONTRAFECT CORP's (NASDAQ:CFRX) shares fell 23.45% to $0.07. The stock is trading 47.7% lower than 3 months ago.
COMS-17.48%COMSOVEREIGN HOLDING CORP's (NASDAQ:COMS) stock price is declining with 17.48% to a price of $0.09. After running up 58.84% in yesterday's session, NASDAQ:COMS is pulling back pre-market.
XRTX-15.46%XORTX THERAPEUTICS INC's (NASDAQ:XRTX) shares fell 15.46% to $0.58 during Friday's pre-market session. In the last month the share price dropped with 25.99%.
MDNA-15.44%MEDICENNA THERAPEUTICS CORP's (NASDAQ:MDNA) stock price decreased by 15.44% to $0.63. Prices are quite volatile now: this is a reversal from yesterday's 22.23% gain.
INBS-13.54%INTELLIGENT BIO SOLUTIONS IN's (NASDAQ:INBS) stock price decreased by 13.54% to $0.83. Yesterday's drop of -22.58% continued in today's pre-market session with another decline of 13.54%
UTRS-12.79%MINERVA SURGICAL INC's (NASDAQ:UTRS) stock price is declining with 12.79% to a price of $0.38. Prices are quite volatile now: this is a reversal from yesterday's 13.19% gain.
MIR-11.16%MIRION TECHNOLOGIES INC's (NYSE:MIR) shares fell 11.16% to $7.0 during Friday's pre-market session.
INTC-10.9%INTEL CORP's (NASDAQ:INTC) shares fell 10.9% to $26.81. In the last year the share price dropped with 36.96%.
MEDS-10.34%TRXADE HEALTH INC's (NASDAQ:MEDS) stock price is declining with 10.34% to a price of $0.42. Prices are quite volatile now: this is a reversal from yesterday's 20.51% gain.

Our premarket losers screener will show you the full list.

Back

REDHILL BIOPHARMA LTD-SP ADR

NASDAQ:RDHL (4/18/2024, 7:17:03 PM)

After market: 0.4199 0 (-0.21%)

0.4208

+0.04 (+9.16%)

RDHL News

News Image10 days ago - RedHill Biopharma Ltd.RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights

RedHill continues corporate transformation to focus on U.S. government-funded pipeline development in underserved, sizeable therapeutic areas with a...

News Image17 days ago - RedHill Biopharma Ltd.RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...

News Imagea month ago - RedHill Biopharma Ltd.RedHill Announces New USPTO Patent Covering Talicia® Through 2034

U.S. Patent and Trademark Office (USPTO) issues new patent covering Talicia1 as an all-in-one treatment of Helicobacter pylori (H. pylori), supporting Talicia...

News Imagea month ago - RedHill Biopharma Ltd.RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs

The U.S. government's Chemical Medical Countermeasures (Chem MCM) Program and Chemical Countermeasures Research Program (CCRP), managed respectively by...

News Image2 months ago - Seeking AlphaRedHill Biopharma files to sell 10.6M ADS for holders (NASDAQ:RDHL)

Read about RedHill Biopharma's filing of a prospectus for the resale of 10.6M ADSs, representing 400 shares each, by selling stockholders.

News Image3 months ago - RedHill Biopharma Ltd.RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering

/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has closed...

News Image3 months ago - RedHill Biopharma Ltd.RedHill Biopharma Announces $8 Million Registered Direct Offering

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...

News Image3 months ago - Seeking AlphaRedHill gains on patent grant for Talicia for H. pylori treatment (NASDAQ:RDHL)

RedHill Biopharma's new patent for Talicia, a method for eradicating H.

News Image3 months ago - RedHill Biopharma Ltd.RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042

USPTO issues new patent covering Talicia[1] as a method for eradicating H. pylori regardless of patient Body Mass Index (BMI)[2], supporting Talicia protection...

RDHL Links
Follow us for more